<DOC>
	<DOCNO>NCT01800097</DOCNO>
	<brief_summary>This study investigator initiate placebo control double blind trial . The hypothesis treatment modafinil positively affect behavioural cognitive rehabilitation stroke , cause treatment group experience decrease fatigue , increase endurance , improve skill sustain attention faster reaction time . The cognitive rehabilitation show increase muscle mass , decrease osteoporosis well physical performance due high level physical activity .</brief_summary>
	<brief_title>Treatment Post Stroke Fatigue With Wakefulness Promoting Agent</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Wakefulness-Promoting Agents</mesh_term>
	<criteria>18 year age stroke within 14 day Modified Rankin Scale 3 Barthel 85 stroke Person understand instruction test questionnaires support give informed consent MFI20 score 12 Infertile person fertile woman test negative pregnancy use safe anticonception Dementia neuropsychiatric disease make person incapable understanding instruction Other disease fatigue know symptom stroke induce trauma , infection surgical procedure former drug abuse know contraindication treatment modafinil know active malignancy , benign intracranial tumor , subdural epidural bleed kidneydysfunction creatinin 265 micromol/L liver disease ASAT ( aspartate aminotransferase ) elevate 70 U/L woman 100 U/L men . allergy project treatment use benzodiazepin antiepileptic drug fix dose . Sleeping pill include . Patients thread ciclosporin anti HIV medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>stroke</keyword>
	<keyword>fatigue</keyword>
	<keyword>modafinil</keyword>
</DOC>